Blog

Detroit Pistons team owner Tom Gores claps during the press conference on July 30, 2021 at the Pistons Performance Center in Detroit, Michigan. Nic Antaya | Getty Images Sport | Getty ImagesPrivate equity billionaire Tom Gores has agreed to pay $750 million to buy 27% of the National Football League's Los Angeles Chargers at an enterprise value of $4 billion, according to two people with knowledge of the deal who spoke on the condition of anonymity to discuss nonpublic details.The $4 billion valuation is more than a 30% discount to the team's value of $5.83 billion, according to CNBC's Official 2024 NFL Team Valuations. Limited partners with no path to control of the team typically get about a 20% to 25% discount in these deals.Gores likely got a larger than usual discount because he bough...

Barclays has named a raft of global stocks for investors to consider buying before the end of the year, naming "conviction stock ideas with catalysts." The bank's list includes six overweight-rated stocks from the U.K., which it gave an average upside potential of 25%. In explaining why they maintained their overweight rating for U.K. stocks, the bank's analysts said in an Oct. 11 equity research note that "hopes for domestic recovery are still present," though they noted that "sentiment is cautious going into October budget." "UK stocks overall are still very under-owned and look very cheap. FTSE100 is short Tech but a broadening-out of the rally benefits the value/defensive-tilted index for now," they wrote. The analysts also noted that U.K. domestic plays could benefit from "reduced unc...

Nine health-care stocks have more than doubled in price this year, but still have more than 100% upside potential, according to analysts. CNBC Pro screened more than 85,000 firms worldwide for stocks that have risen by 100% so far in 2024. They are all covered by at least five or more analysts, and a have a median price target pointing to more than 100% upside potential over the next 12 months. The Nasdaq-listed stocks are Jasper Therapeutics , Corbus Pharmaceuticals , Rezolute , Trevi Therapeutics , Delcath Systems , Benitec Biopharma , Arcutis Biotherapeutics , Praxis Precision Medicines and Humacyte . Stocks in the biotechnology sector are typically classed by analysts as carrying higher risk for investors than other sectors. Jasper Therapeutics Jasper Therapeutics is a clinical-stage b...

Vice President and Democratic presidential candidate Kamala Harris arrives for a campaign event at the Dort Financial Center in Flint, Michigan, October 4, 2024. Geoff Robins | Afp | Getty ImagesKamala Harris on Wednesday distanced herself from President Joe Biden and bashed her Republican presidential rival Donald Trump in a heated interview with Fox News anchor Brett Baier."Let me be very clear, my presidency will not be a continuation of Joe Biden's presidency," Harris said on the conservative news network, after Baier pressed her on whether the vice president would do anything differently than the incumbent."And like every new president that comes in to office, I will bring my life experiences, my professional experiences, and fresh and new ideas," the Democratic nominee said.The 26-mi...